Bnp Paribas Arbitrage, Snc »

Castle Biosciences shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.8M 150k 38.90
2025-09-30 $3.2M 140k 22.77
2025-06-30 $2.0M 99k 20.42
2025-03-31 $906k 45k 20.02
2024-12-31 $6.6M 249k 26.65

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
Amazon.com Equity (AMZN)
Meta Platforms Equity (META)
Tesla Equity (TSLA)
Alphabet Equity (GOOGL)
JPMorgan Chase & Co Equity (JPM)
Broadcom Equity (AVGO)
State Street SPDR S&P Biotech ETF Fund (XBI)
Alphabet Equity (GOOG)
State Street SPDR S&P 500 ETF Trust Fund (SPY)
Cisco Systems Equity (CSCO)
Micron Technology Equity (MU)
Advanced Micro Devices Equity (AMD)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Castle Biosciences

BlackRock
Vanguard Group
Rtw Investments
Principal Financial Group
Portolan Capital Management
Dimensional Fund Advisors
Summit Partners Public Asset Management
State Street Corporation
Geode Capital Management
Palisade Capital Management
AIGH Capital Management
Allianz Asset Management
Millennium Management
Daniel D. Thurber
Nuveen

View all funds holding Castle Biosciences